CareRx Corp (CRRX) - Net Assets
Based on the latest financial reports, CareRx Corp (CRRX) has net assets worth CA$109.50 Million CAD (≈ $79.21 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$253.02 Million ≈ $183.03 Million USD) and total liabilities (CA$143.51 Million ≈ $103.82 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of CareRx Corp to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$109.50 Million |
| % of Total Assets | 43.28% |
| Annual Growth Rate | 31.49% |
| 5-Year Change | 33.08% |
| 10-Year Change | 3618.3% |
| Growth Volatility | 217.84 |
CareRx Corp - Net Assets Trend (2002–2025)
This chart illustrates how CareRx Corp's net assets have evolved over time, based on quarterly financial data. Also explore total assets of CareRx Corp for the complete picture of this company's asset base.
Annual Net Assets for CareRx Corp (2002–2025)
The table below shows the annual net assets of CareRx Corp from 2002 to 2025. For live valuation and market cap data, see CRRX company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CA$109.50 Million ≈ $79.21 Million |
+30.01% |
| 2024-12-31 | CA$84.23 Million ≈ $60.93 Million |
+3.31% |
| 2023-12-31 | CA$81.53 Million ≈ $58.97 Million |
+26.48% |
| 2022-12-31 | CA$64.46 Million ≈ $46.63 Million |
-21.67% |
| 2021-12-31 | CA$82.29 Million ≈ $59.53 Million |
+628.01% |
| 2020-12-31 | CA$11.30 Million ≈ $8.18 Million |
+156.63% |
| 2019-12-31 | CA$-19.96 Million ≈ $-14.44 Million |
-160.83% |
| 2018-12-31 | CA$-7.65 Million ≈ $-5.54 Million |
-138.01% |
| 2017-12-31 | CA$20.13 Million ≈ $14.56 Million |
+583.60% |
| 2016-12-31 | CA$2.94 Million ≈ $2.13 Million |
-80.29% |
| 2015-12-31 | CA$14.95 Million ≈ $10.81 Million |
+143.94% |
| 2014-12-31 | CA$-34.01 Million ≈ $-24.61 Million |
-328.08% |
| 2013-12-31 | CA$14.91 Million ≈ $10.79 Million |
-84.19% |
| 2012-12-31 | CA$94.34 Million ≈ $68.24 Million |
+53.11% |
| 2011-12-31 | CA$61.62 Million ≈ $44.57 Million |
+172.94% |
| 2010-12-31 | CA$22.58 Million ≈ $16.33 Million |
+42.68% |
| 2009-12-31 | CA$15.82 Million ≈ $11.45 Million |
+123.81% |
| 2008-12-31 | CA$7.07 Million ≈ $5.11 Million |
+17.20% |
| 2007-12-31 | CA$6.03 Million ≈ $4.36 Million |
+156.26% |
| 2006-12-31 | CA$2.35 Million ≈ $1.70 Million |
+5.09% |
| 2005-12-31 | CA$2.24 Million ≈ $1.62 Million |
-8.06% |
| 2004-12-31 | CA$2.44 Million ≈ $1.76 Million |
+326.69% |
| 2003-12-31 | CA$571.00K ≈ $413.05K |
+183.19% |
| 2002-12-31 | CA$201.63K ≈ $145.86K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to CareRx Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 26351892200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CA$332.49 Million | 303.63% |
| Other Components | CA$40.59 Million | 37.07% |
| Total Equity | CA$109.50 Million | 100.00% |
CareRx Corp Competitors by Market Cap
The table below lists competitors of CareRx Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Omiris AG
F:HBD1
|
$167.69 Million |
|
LIWANLI Innovation Co Ltd
TW:3054
|
$167.70 Million |
|
Answer Technology Co Ltd
TW:3528
|
$167.72 Million |
|
Ubiquoss Holdings Inc
KQ:078070
|
$167.73 Million |
|
Mendelson Infrastructures and Industries Ltd
TA:MNIN
|
$167.51 Million |
|
Sea Sonic Electronics Co Ltd
TWO:6203
|
$167.45 Million |
|
Seronics Co. Ltd
KQ:042600
|
$167.44 Million |
|
Astec LifeSciences Limited
NSE:ASTEC
|
$167.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CareRx Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 84,228,000 to 109,504,000, a change of 25,276,000 (30.0%).
- Net income of 26,127,000 contributed positively to equity growth.
- Share repurchases of 2,239,000 reduced equity.
- Other comprehensive income decreased equity by 583,000.
- Other factors increased equity by 1,971,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$26.13 Million | +23.86% |
| Share Repurchases | CA$2.24 Million | -2.04% |
| Other Comprehensive Income | CA$-583.00K | -0.53% |
| Other Changes | CA$1.97 Million | +1.8% |
| Total Change | CA$- | 30.01% |
Book Value vs Market Value Analysis
This analysis compares CareRx Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.17x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.90x to 2.17x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | CA$1.27 | CA$3.69 | x |
| 2003-12-31 | CA$0.66 | CA$3.69 | x |
| 2004-12-31 | CA$2.24 | CA$3.69 | x |
| 2005-12-31 | CA$1.70 | CA$3.69 | x |
| 2006-12-31 | CA$1.86 | CA$3.69 | x |
| 2007-12-31 | CA$3.72 | CA$3.69 | x |
| 2008-12-31 | CA$3.49 | CA$3.69 | x |
| 2009-12-31 | CA$4.80 | CA$3.69 | x |
| 2010-12-31 | CA$6.21 | CA$3.69 | x |
| 2011-12-31 | CA$11.93 | CA$3.69 | x |
| 2012-12-31 | CA$12.15 | CA$3.69 | x |
| 2013-12-31 | CA$1.53 | CA$3.69 | x |
| 2014-12-31 | CA$-4.85 | CA$3.69 | x |
| 2015-12-31 | CA$1.79 | CA$3.69 | x |
| 2016-12-31 | CA$0.31 | CA$3.69 | x |
| 2017-12-31 | CA$2.02 | CA$3.69 | x |
| 2018-12-31 | CA$-0.77 | CA$3.69 | x |
| 2019-12-31 | CA$-1.82 | CA$3.69 | x |
| 2020-12-31 | CA$0.56 | CA$3.69 | x |
| 2021-12-31 | CA$2.36 | CA$3.69 | x |
| 2022-12-31 | CA$1.35 | CA$3.69 | x |
| 2023-12-31 | CA$1.42 | CA$3.69 | x |
| 2024-12-31 | CA$1.40 | CA$3.69 | x |
| 2025-12-31 | CA$1.70 | CA$3.69 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CareRx Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 23.86%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.06%
- • Asset Turnover: 1.46x
- • Equity Multiplier: 2.31x
- Recent ROE (23.86%) is above the historical average (-49.90%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | -29.30% | 0.00% | 0.00x | 1.16x | CA$-79.24K |
| 2003 | 106.04% | 8.86% | 3.57x | 3.36x | CA$548.38K |
| 2004 | 5.36% | 1.83% | 1.82x | 1.61x | CA$-113.03K |
| 2005 | -15.54% | -3.69% | 2.17x | 1.94x | CA$-572.09K |
| 2006 | 2.10% | 0.40% | 2.86x | 1.83x | CA$-185.93K |
| 2007 | 14.06% | 5.30% | 1.65x | 1.61x | CA$218.06K |
| 2008 | 14.75% | 6.03% | 1.76x | 1.39x | CA$306.53K |
| 2009 | 10.36% | 4.48% | 1.16x | 2.00x | CA$57.70K |
| 2010 | 19.17% | 6.93% | 1.12x | 2.46x | CA$2.07 Million |
| 2011 | -14.69% | -4.47% | 0.46x | 7.14x | CA$-15.10 Million |
| 2012 | -7.76% | -1.66% | 0.90x | 5.19x | CA$-16.62 Million |
| 2013 | -642.62% | -19.98% | 1.16x | 27.60x | CA$-92.51 Million |
| 2014 | 0.00% | -18.65% | 0.98x | 0.00x | CA$-53.93 Million |
| 2015 | 322.66% | 28.37% | 0.43x | 26.44x | CA$44.65 Million |
| 2016 | -761.79% | -11.76% | 1.08x | 60.04x | CA$-19.94 Million |
| 2017 | 9.38% | 1.09% | 1.17x | 7.34x | CA$-121.70K |
| 2018 | 0.00% | -25.13% | 1.01x | 0.00x | CA$-30.31 Million |
| 2019 | 0.00% | -36.65% | 1.43x | 0.00x | CA$-43.68 Million |
| 2020 | -160.87% | -11.21% | 1.04x | 13.81x | CA$-19.31 Million |
| 2021 | -27.62% | -8.65% | 0.93x | 3.44x | CA$-30.96 Million |
| 2022 | -53.30% | -9.00% | 1.44x | 4.10x | CA$-40.80 Million |
| 2023 | -6.63% | -1.46% | 1.60x | 2.84x | CA$-13.56 Million |
| 2024 | -5.34% | -1.23% | 1.64x | 2.65x | CA$-12.92 Million |
| 2025 | 23.86% | 7.06% | 1.46x | 2.31x | CA$15.18 Million |
Industry Comparison
This section compares CareRx Corp's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $302,967,154
- Average return on equity (ROE) among peers: -17.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CareRx Corp (CRRX) | CA$109.50 Million | -29.30% | 1.31x | $167.61 Million |
| HealWELL AI Inc. (AIDX) | $123.94 Million | -37.87% | 1.30x | $201.58 Million |
| dentalcorp Holdings Ltd (DNTL) | $1.79 Billion | -0.93% | 0.89x | $1.52 Billion |
| Medical Facilities Corporation (DR) | $114.69 Million | -3.84% | 2.29x | $218.65 Million |
| Element Lifestyle Retirement Inc (ELM) | $-590.09K | 0.00% | 0.00x | $509.83K |
| Extendicare Inc (EXE) | $658.62 Million | 9.92% | 2.37x | $2.06 Billion |
| Jack Nathan Medical Corp (JNH) | $8.52 Million | -116.33% | 0.25x | $68.71 |
| KDA Group Inc (KDA) | $-3.65 Million | 0.00% | 0.00x | $16.18 Million |
| Nova Leap Health Corp (NLH) | $9.84 Million | 12.76% | 0.78x | $24.32 Million |
| NeuPath Health Inc (NPTH) | $27.62 Million | -18.31% | 0.67x | $22.40 Million |
About CareRx Corp
CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company offers medication management, technology, and program services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to Ca… Read more